APA (7th ed.) Citation

Zhang, J., Wu, Z., Wang, S., Sun, Y., Wu, J., Wang, D., . . . Sun, Y. (2025, July). Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancer. BMC Cancer.

Chicago Style (17th ed.) Citation

Zhang, Jian, et al. "Efficacy of PD-(L)1 Inhibitors Plus Anlotinib in the Second-line Treatment of Extensive-stage Small Cell Lung Cancer." BMC Cancer Jul. 2025.

MLA (9th ed.) Citation

Zhang, Jian, et al. "Efficacy of PD-(L)1 Inhibitors Plus Anlotinib in the Second-line Treatment of Extensive-stage Small Cell Lung Cancer." BMC Cancer, Jul. 2025.